SUNLENCA® (lenacapavir) is an injectable prescription medicine used to treat HIV-1, together with other HIV-1 medicines, in adults with HIV-1 that meet ...

SUNLENCA injection is only for subcutaneous administration into the abdomen by a healthcare provider. Do NOT administer intradermally due to risk of serious ...

SUNLENCA Is a Long-acting SC Injectable Administered Only Twice a Year · Maintenance injections are given once every 26 weeks (±2 weeks) from the date of ...

SUNLENCA is an injectable treatment for HIV with a twice-a-year dosing schedule. SUNLENCA can help you treat your HIV when used in combination with the other ...

Sunlenca is used, together with other medicines, to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune ...

Sunlenca (lenacapavir) is used for the treatment of HIV-1 infection in heavily treatment-experienced people with multi-drug resistant (MDR) HIV-1 infection. Uses · Side effects · Before taking · Directions

SUNLENCA, in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.

Store at 20°C to 25°C (68°F–77°F), excursions permitted to 15°C to 30°C (59°F–86°F).

Lenacapavir, sold under the brand name Sunlenca, is an antiretroviral medication used to treat HIV/AIDS. It is taken by mouth or by subcutaneous injection. Medical uses · History · Society and culture

Sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant HIV-1 infection for whom it ...